| Alessandra Boufford, MD | |
|
1 Akron General Ave, Akron, OH 44307-2432 | |
| (330) 344-6000 | |
| Not Available |
| Full Name | Alessandra Boufford |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 8 Years |
| Location | 1 Akron General Ave, Akron, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154783611 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 35.136426 (Ohio) | Primary |
| 207R00000X | Internal Medicine | 35.136426 (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aultman Hospital | Canton, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohio Physician Professional Corporation | 2668406059 | 105 |
News Archive
Researchers have discovered a possible explanation for the surprisingly large range of biological effects that are linked to a micronutrient called lipoic acid: It appears to reset and synchronize circadian rhythms, or the "biological clock" found in most life forms.
A novel strategy of blocking the growth of blood vessels with antibodies should result in improved treatment of cancerous tumors.
With the rapid spread of the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout the world, causing the current COVID-19 pandemic, there is an urgent need for new antivirals and vaccines to combat its spread. The current study published on the preprint server bioRxiv in June 2020 shows some of the results of the extensive repurposing of already FDA-approved drugs.
Israeli and Palestinian researchers have conducted a large scale epidemiological study examining risk factors for a form of Non-Hodgkin Lymphoma in these two populations.
› Verified 7 days ago
| Entity Name | Ohio Physician Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417016973 PECOS PAC ID: 2668406059 Enrollment ID: O20050925000062 |
News Archive
Researchers have discovered a possible explanation for the surprisingly large range of biological effects that are linked to a micronutrient called lipoic acid: It appears to reset and synchronize circadian rhythms, or the "biological clock" found in most life forms.
A novel strategy of blocking the growth of blood vessels with antibodies should result in improved treatment of cancerous tumors.
With the rapid spread of the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout the world, causing the current COVID-19 pandemic, there is an urgent need for new antivirals and vaccines to combat its spread. The current study published on the preprint server bioRxiv in June 2020 shows some of the results of the extensive repurposing of already FDA-approved drugs.
Israeli and Palestinian researchers have conducted a large scale epidemiological study examining risk factors for a form of Non-Hodgkin Lymphoma in these two populations.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alessandra Boufford, MD 1 Akron General Ave, Akron, OH 44307-2432 Ph: (330) 344-6000 | Alessandra Boufford, MD 1 Akron General Ave, Akron, OH 44307-2432 Ph: (330) 344-6000 |
News Archive
Researchers have discovered a possible explanation for the surprisingly large range of biological effects that are linked to a micronutrient called lipoic acid: It appears to reset and synchronize circadian rhythms, or the "biological clock" found in most life forms.
A novel strategy of blocking the growth of blood vessels with antibodies should result in improved treatment of cancerous tumors.
With the rapid spread of the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout the world, causing the current COVID-19 pandemic, there is an urgent need for new antivirals and vaccines to combat its spread. The current study published on the preprint server bioRxiv in June 2020 shows some of the results of the extensive repurposing of already FDA-approved drugs.
Israeli and Palestinian researchers have conducted a large scale epidemiological study examining risk factors for a form of Non-Hodgkin Lymphoma in these two populations.
› Verified 7 days ago
Dr. Sara Kathryn Keller, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 75 Arch St Ste 401, Akron, OH 44304 Phone: 330-867-6460 | |
Pallavi Reddy, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-363-6000 | |
Charles Oppong, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Medical Dr, Akron General Medical Center, Akron, OH 44307 Phone: 330-344-6000 |